SYNTHON S.R.O.

Please note that the designation "S.R.O." (Spoločnosť s ručením obmedzeným) is a legal form for a limited liability company typically used in countries like Slovakia and the Czech Republic, not India. There is no widely recognized Indian company named "SYNTHON S.R.O."

However, Synthon, a global pharmaceutical company headquartered in the Netherlands, has a significant presence in India through its subsidiary, which is known as Synthon Pharmaceuticals India Private Limited. The information below pertains to Synthon Pharmaceuticals India Private Limited.

Company Introduction:

Synthon Pharmaceuticals India Private Limited is a key subsidiary of Synthon B.V., a leading global pharmaceutical company based in the Netherlands. This Indian entity is strategically important for Synthon's global operations, focusing on the research, development, and manufacturing of complex generic active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Located in Hyderabad, India, the company operates state-of-the-art facilities that support various stages of pharmaceutical production, from early-stage development and analytical testing to large-scale commercial manufacturing. Synthon Pharmaceuticals India Private Limited plays a vital role in bringing affordable, high-quality generic medicines to patients worldwide across diverse therapeutic areas.

Factory or Trader:

Synthon Pharmaceuticals India Private Limited is primarily a factory (manufacturer). Its core business involves the development, production, and synthesis of pharmaceutical ingredients and products. While it engages in the commercialization and distribution of its manufactured goods, its fundamental identity and main operational function are rooted in manufacturing.

SYNTHON S.R.O. through its operations in India, primarily via Synthon Pharmaceuticals Pvt Ltd, focuses on the sale and distribution of a diverse portfolio of generic pharmaceutical products. These products typically include:

Oncology products: Generic versions of medicines for cancer treatment. Examples of active pharmaceutical ingredients in their portfolio include Capecitabine, Everolimus, Imatinib, Lapatinib, Lenalidomide, Pazopanib, Sunitinib, and Temozolomide.

Central Nervous System (CNS) products: Generic medicines for neurological conditions. An example active pharmaceutical ingredient is Glatiramer Acetate.

Women's Health products: Generic oral contraceptives and hormone replacement therapies.

Cardiovascular products: Certain generic medications for cardiovascular diseases.

The specific product availability in India may vary based on local market approvals and commercial strategies.